Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Haffkine Biopharmaceutical Corporation Ltd

http://www.vaccinehaffkine.com

Latest From Haffkine Biopharmaceutical Corporation Ltd

Pediatric COVID-19 Vaccine Face-Off Looms As Bharat Biotech Heads For Approval

While Bharat Biotech is close to an accelerated approval of Covaxin in two to 18-year-olds, Zydus Cadila is yet to roll out its COVID-19 vaccine in India. As they head to a face-off in pediatric vaccines, the former faces manufacturing constraints and the latter hesitance over a first of its kind DNA vaccine. Experts speak to Scrip on which one stands a better chance of winning.

Coronavirus COVID-19 Vaccines

Focus On J&J, Pfizer COVID-19 Vaccine Pricing As India Permits Private Sales

Prices for J&J and Pfizer’s COVID-19 vaccines will be watched closely as India permits private sales. While demand is set to spike with age criteria for those eligible to receive the shots expanded, local manufacturers Serum Institute and Bharat Biotech are ramping up capacities with the government’s help.

India Coronavirus COVID-19
See All

Company Information

UsernamePublicRestriction

Register